These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 34880614)

  • 21. Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease.
    Tang R; Li R; Li H; Ma XL; Du P; Yu XY; Ren L; Wang LL; Zheng WS
    ACS Nano; 2021 Nov; 15(11):17016-17046. PubMed ID: 34705426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exciting Potential of Nanoparticlized Lipidic System for Effective Treatment of Breast Cancer and Clinical Updates: A Translational Prospective.
    Harwansh RK; Bahadur S; Deshmukh R; Rahman MA
    Curr Pharm Des; 2020; 26(11):1191-1205. PubMed ID: 32003686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Yap KM; Sekar M; Seow LJ; Gan SH; Bonam SR; Mat Rani NNI; Lum PT; Subramaniyan V; Wu YS; Fuloria NK; Fuloria S
    Breast Cancer (Dove Med Press); 2021; 13():471-503. PubMed ID: 34548817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
    Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
    ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Breast Cancer Signaling via Phytomedicine and Nanomedicine.
    Ansari JA; Malik JA; Ahmed S; Bhat FA; Khanam A; Mir SA; Abouzied AS; Ahemad N; Anwar S
    Pharmacology; 2023; 108(6):504-520. PubMed ID: 37748454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome vesicle as a nano-therapeutic carrier for breast cancer.
    Mughees M; Kumar K; Wajid S
    J Drug Target; 2021 Feb; 29(2):121-130. PubMed ID: 32787592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoformulation of Plant-Based Natural Products for Type 2 Diabetes Mellitus: From Formulation Design to Therapeutic Applications.
    Wickramasinghe ASD; Kalansuriya P; Attanayake AP
    Curr Ther Res Clin Exp; 2022; 96():100672. PubMed ID: 35586563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
    Lv L; Shi Y; Wu J; Li G
    Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue Engineering Scaffolds Loaded With a Variety of Plant Extracts: Novel Model in Breast Cancer Therapy.
    Azhari Rad R; Naghdi Y; Majidi Jamalabadi M; Masoumi S; Rezakhani L; Alizadeh M
    Breast Cancer (Auckl); 2024; 18():11782234241236358. PubMed ID: 38476474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
    Challal S; Skiba A; Langlois M; Esguerra CV; Wolfender JL; Crawford AD; Skalicka-Woźniak K
    J Ethnopharmacol; 2023 Dec; 317():116740. PubMed ID: 37315641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring natural products-based cancer therapeutics derived from egyptian flora.
    El-Seedi HR; Yosri N; Khalifa SAM; Guo Z; Musharraf SG; Xiao J; Saeed A; Du M; Khatib A; Abdel-Daim MM; Efferth T; Göransson U; Verpoorte R
    J Ethnopharmacol; 2021 Apr; 269():113626. PubMed ID: 33248183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano-scale drug delivery systems for luteolin: advancements and applications.
    Shang J; Yang J; Deng Q; Zhou M
    J Mater Chem B; 2023 Dec; 11(47):11198-11216. PubMed ID: 37986608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.
    Bonofiglio D; Giordano C; De Amicis F; Lanzino M; Andò S
    Mini Rev Med Chem; 2016; 16(8):596-604. PubMed ID: 26156544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticulate drugs and vaccines: Breakthroughs and bottlenecks of repurposing in breast cancer.
    Kumbhar P; Kole K; Khadake V; Marale P; Manjappa A; Nadaf S; Jadhav R; Patil A; Singh SK; Dua K; Jha NK; Disouza J; Patravale V
    J Control Release; 2022 Sep; 349():812-830. PubMed ID: 35914614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanomedicine as a Strategy for Natural Compound Delivery to Prevent and Treat Cancers.
    Aljuffali IA; Fang CL; Chen CH; Fang JY
    Curr Pharm Des; 2016; 22(27):4219-31. PubMed ID: 27323758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects and mechanisms of dietary bioactive compounds on breast cancer prevention.
    Ganesan K; Du B; Chen J
    Pharmacol Res; 2022 Apr; 178():105974. PubMed ID: 34818569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer.
    Halder J; Pradhan D; Biswasroy P; Rai VK; Kar B; Ghosh G; Rath G
    J Drug Target; 2022 Dec; 30(10):1055-1075. PubMed ID: 35786242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel nano-drug delivery system for natural products and their application.
    Huang L; Huang XH; Yang X; Hu JQ; Zhu YZ; Yan PY; Xie Y
    Pharmacol Res; 2024 Mar; 201():107100. PubMed ID: 38341055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.